JFS Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.6K Buy
62
+2
+3% +$1.12K ﹤0.01% 636
2026
Q1
$33.7K Sell
60
-1
-2% -$641 ﹤0.01% 603
2025
Q4
$41.3K Buy
61
+12
+24% +$8.17K ﹤0.01% 577
2025
Q3
$31.3K Hold
49
﹤0.01% 597
2025
Q2
$26.3K Sell
49
-5
-9% -$2.39K ﹤0.01% 601
2025
Q1
$22.7K Sell
54
-16
-23% -$6.95K ﹤0.01% 633
2024
Q4
$28.9K Hold
70
﹤0.01% 552
2024
Q3
$35.4K Buy
70
+1
+1% +$486 ﹤0.01% 526
2024
Q2
$33.6K Hold
69
﹤0.01% 486
2024
Q1
$37.3K Sell
69
-1
-1% -$546 ﹤0.01% 491
2023
Q4
$38.9K Buy
70
+45
+180% +$21.1K ﹤0.01% 452
2023
Q3
$10.9K Sell
25
-1
-4% -$499 ﹤0.01% 700
2023
Q2
$13.1K Sell
26
-3
-10% -$1.44K ﹤0.01% 649
2023
Q1
$14.5K Buy
29
+3
+12% +$1.44K ﹤0.01% 603
2022
Q4
$10.6K Buy
26
+2
+8% +$776 ﹤0.01% 684
2022
Q3
$8K Buy
24
+4
+20% +$1.47K ﹤0.01% 806
2022
Q2
$7K Sell
20
-79
-80% -$32.2K ﹤0.01% 878
2022
Q1
$54K Hold
99
0.01% 409
2021
Q4
$65K Hold
99
0.01% 376
2021
Q3
$62K Buy
+99
New +$66.5K 0.01% 383

Other funds holding IDXX

JFS Wealth Advisors's IDXX Position: Q2 2026 in Review

JFS Wealth Advisors increased its Idexx Laboratories (IDXX) stake by 3.3% in Q2 2026, buying an estimated $1.12K and bringing the position to 62 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

JFS Wealth Advisors first reported a position in IDXX in Q3 2021 and has held it in 20 quarters since. The position peaked at $65K in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • JFS Wealth Advisors held 62 shares of Idexx Laboratories worth $32.6K as of Q2 2026.
  • JFS Wealth Advisors bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #636 holding.
  • JFS Wealth Advisors first reported a position in Idexx Laboratories in Q3 2021 and has held it in 20 quarters since.
  • JFS Wealth Advisors's Idexx Laboratories position peaked at $65K in Q4 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.